
Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
latest_posts
- 1
Brazilian cardinal orders a popular Catholic priest to go offline following right-wing attacks - 2
Cheetos and Doritos to launch new versions without artificial dyes - 3
The Most Compelling Innovation Developments Somewhat recently - 4
The Extraordinary Excursion of Dental Embed Innovation - 5
More people are addicted to marijuana, but fewer of them are seeking help, experts say
Choosing the Ideal Bed for Quality Rest and Solace
Iran war fuels fears of new inflation wave among German consumers
Eleven arrested over mass shooting in South Africa tavern
Holiday season sees uptick in norovirus cases, according to CDC
6 Novice Cameras for 2024: Ideal for New Picture takers
Find the Lively Food Markets of South America
Four Dead in Last Month From Animal Attacks in Nepal
‘Wu-Tang Forever: The Final Chamber’ tour — How to get tickets, presale times, concert dates and more
The Best Cell phone Brands for Tech Lovers













